Stocks
Axsome Therapeutics (AXSM) ROA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROA, % | ? | -56.6% | 39.9% | -56.5% | -59.7% | -40.7% | -55.4% | ||
| Changes by years, y/y, % | -25pp | +97pp | -96pp | -3pp | +19pp | -27.4% | |||
Axsome Therapeutics. ROA, %
Axsome Therapeutics. ROA, changes, pp
Axsome Therapeutics (AXSM) ROA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROA, % | ? | -34.5% | -40.7% | -54.3% | -56.3% | -55.4% | -55.4% | |
| Changes by years, y/y, % | +15pp | +19pp | -11pp | -25pp | -21pp | |||
| Changes by quarters, q/q, % | -3pp | -6pp | -14pp | -2pp | +1pp | |||
